Sponsor

Rottapharm Biotech S.r.l.

Italy Via Valosa Di Sopra 9, 20900 Monza, Italy

About the sponsor

Rottapharm Biotech S.r.l. is active in metastatic colorectal cancer, with a focus on mismatch-repair-proficient and microsatellite stable disease after prior treatment.

pMMR and MSS metastatic colorectal cancer
Pretreated advanced gastrointestinal malignancy
Immuno-oncology combinations

The sponsor’s research interest in this area centres on advanced colorectal cancer where standard immune responsiveness is limited, with attention to therapeutic strategies that may expand treatment options in resistant disease.

About Specializations

Rottapharm Biotech S.r.l. runs clinical trials in conditions such as Colorectal cancer metastatic, Gastrointestinal cancer metastatic, Mismatch repair cancer syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Colorectal cancer metastatic+2

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Balstilimab
Sponsor:Rottapharm Biotech S.r.l.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →